These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
713 related items for PubMed ID: 26844205
1. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity. Nixon M, Stewart-Fitzgibbon R, Fu J, Akhmedov D, Rajendran K, Mendoza-Rodriguez MG, Rivera-Molina YA, Gibson M, Berglund ED, Justice NJ, Berdeaux R. Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205 [Abstract] [Full Text] [Related]
2. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. Mottillo EP, Desjardins EM, Fritzen AM, Zou VZ, Crane JD, Yabut JM, Kiens B, Erion DM, Lanba A, Granneman JG, Talukdar S, Steinberg GR. Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278 [Abstract] [Full Text] [Related]
3. Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance. White AT, LaBarge SA, McCurdy CE, Schenk S. Mol Metab; 2015 Aug; 4(8):569-75. PubMed ID: 26266089 [Abstract] [Full Text] [Related]
5. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes. Lee JM, Han HS, Jung YS, Harris RA, Koo SH, Choi HS. J Biol Chem; 2018 Aug 24; 293(34):13125-13133. PubMed ID: 29950523 [Abstract] [Full Text] [Related]
6. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. Babu PV, Liu D, Gilbert ER. J Nutr Biochem; 2013 Nov 24; 24(11):1777-89. PubMed ID: 24029069 [Abstract] [Full Text] [Related]
7. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells. Gu L, Ding X, Wang Y, Gu M, Zhang J, Yan S, Li N, Song Z, Yin J, Lu L, Peng Y. Int J Biol Sci; 2019 Nov 24; 15(13):2815-2829. PubMed ID: 31853220 [Abstract] [Full Text] [Related]
9. The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice. Marcinko K, Bujak AL, Lally JS, Ford RJ, Wong TH, Smith BK, Kemp BE, Jenkins Y, Li W, Kinsella TM, Hitoshi Y, Steinberg GR. Mol Metab; 2015 Sep 24; 4(9):643-51. PubMed ID: 26413470 [Abstract] [Full Text] [Related]
10. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Houde VP, Brûlé S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A. Diabetes; 2010 Jun 24; 59(6):1338-48. PubMed ID: 20299475 [Abstract] [Full Text] [Related]
16. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice. Jeong KJ, Kim DY, Quan HY, Jo HK, Kim GW, Chung SH. Fitoterapia; 2014 Mar 24; 93():150-62. PubMed ID: 24418657 [Abstract] [Full Text] [Related]
17. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Sun WX, Lou K, Chen LJ, Liu SD, Pang SG. J Endocrinol Invest; 2021 Aug 24; 44(8):1753-1765. PubMed ID: 33423221 [Abstract] [Full Text] [Related]